Critical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and other weight loss agents affect bone density and fracture risk during weight loss.
Key findingCritical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and o
What the researchers found
Critical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and other weight loss agents affect bone density and fracture risk during weight loss.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
No specific numerical outcomes reported; this is a qualitative review of existing evidence across multiple drug classes.
How the study worked
In publication.
Who was studied
People living with obesity using anti-obesity medications
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
The effects of anti-obesity medications on bone metabolism: A critical appraisal.
Diabetes, obesity & metabolism, 27(9), 4674-4688
Citation
Anastasilakis, Athanasios D; Paccou, Julien; Palermo, Andrea; Polyzos, Stergios A. (2025). The effects of anti-obesity medications on bone metabolism: A critical appraisal.. Diabetes, obesity & metabolism, 27(9), 4674-4688. https://doi.org/10.1111/dom.16541